Avitia
Avitia helps clinicians and labs diagnose and treat cancer faster by delivering rapid, on-site molecular testing and clinically actionable reports. It does this through an AI-powered NGS platform that supports non-invasive liquid biopsy workflows, pre-prepared NGS panels, and AI/ML-driven bioinformatics to identify cancer mutations and match patients to targeted therapies or clinical trials. The product is offered as a scalable B2B SaaS solution for clinical laboratories and oncology providers, with integrations for laboratory information management systems (LIMS) and modular on-site testing hardware. Avitia's platform reduces turnaround times and operating costs by avoiding proprietary kits and enabling local testing capacity. The company has processed over 40,000 molecular tests globally and focuses on expanding access to precision oncology in underserved regions.
Avitia
Avitia helps clinicians and labs diagnose and treat cancer faster by delivering rapid, on-site molecular testing and clinically actionable reports. It does this through an AI-powered NGS platform that supports non-invasive liquid biopsy workflows, pre-prepared NGS panels, and AI/ML-driven bioinformatics to identify cancer mutations and match patients to targeted therapies or clinical trials. The product is offered as a scalable B2B SaaS solution for clinical laboratories and oncology providers, with integrations for laboratory information management systems (LIMS) and modular on-site testing hardware. Avitia's platform reduces turnaround times and operating costs by avoiding proprietary kits and enabling local testing capacity. The company has processed over 40,000 molecular tests globally and focuses on expanding access to precision oncology in underserved regions.